DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20221945

Short term effects of antenatal maternal betamethasone administration on CTG

Jayanthy T., Ragvi Raman, Sanvithi Anjanappa

Abstract


Background: Antenatal administration of corticosteroids to pregnant women has proven to enhance lung maturation, prevent respiratory distress syndrome and provide neuroprotection to the foetus. When betamethasone is given antenatally, it has been observed to transiently reduce fetal movements and fetal heart rate variability; which are often used as indicators of fetal wellbeing. Aim and objectives of the present study was planned to assess the short-term effects of antenatal betamethasone administration on fetal heart rate and its variability by visual interpretation of CTG

Methods: A total of 30 women between gestational age of 28 weeks to 36 weeks 6 days with singleton pregnancy requiring maternal betamethasone administration were enrolled and the first CTG was taken. First dose of injection betamethasone 12 mg i.v. was administered and second CTG was taken 6 hours later and both the CTGs were compared.

Results: After 1st dose of antenatal betamethasone, 90% of the cases had changes in fetal heart rate on CTG. In 53.3% cases, the baseline fetal heart rate was reduced while in 46.7% there was no change. There was reduced fetal heart rate variability in 56.7% cases while 23.3% cases had increased variability and rest 20% had no observable change. 73.3% study patients delivered and 26.6% study patients continued pregnancy. Among those who delivered, 20% neonates required neonatal ventilator support and 10% required oxygen support. All neonates were eventually discharged.

Conclusions: Maternal betamethasone administration can cause changes in fetal heart rate and variability on CTG. Hence, other fetal parameters have to be considered before concluding fetal distress as these changes maybe transient. In our study, though CTG changes were seen in 90% cases, only 20% cases required neonatal ventilator support.


Keywords


Betamethasone, Antenatal, CTG, Fetal heart rate

Full Text:

PDF

References


Lunshof M, Boer K, Wolf H. Short-Term (0-48 h) effects of maternal betamethasone administration on fetal heart rate and its variability. Pediatr Res. 2005; 57:545-9.

Magee LA, Dawes GS, Moulden M, Redman CW. A randomised controlled comparison of betamethasone and dexamethasone: effects on the antenatal fetal heart rate. Br J Obstet Gynaecol. 1997;104:1233-8.

Derks JB, Mulder EJ, Visser GH. The effects of maternal betamethasone administration on the fetus. Br J Obstet Gynaecol. 1995;102:40-6.

Subtil D, Tiberghien P, Devos P, Therby D, Leclerc G, Vaast P, et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomized trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. Am J Obstet Gynecol. 2003;188:524-31.

Senat MV, Minoui S, Multon O, Fernandez H, Frydman R, Ville Y. Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labour: a randomised study. Br J Obstet Gynaecol. 1995;105:749-55.

Kelly MK, Schneider EP, Petrikovsky BM, Lesser ML. Effect of antenatal steroid administration on the fetal biophysical profile. J Clin Ultrasound. 2000;28: 224-6.

Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol. 1995;173:322-55.

Mulder EJ, Derks JB, Visser GH. Antenatal corticosteroid therapy and fetal behaviour. a randomized study of the effects of betamethasone and dexamethasone. Br J Obstet Gynaecol. 1997;104: 1239-47.